Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2020

Published by GlobalData Product code 341587
Published Content info 123 Pages
Delivery time: 1-2 business days
Price
Back to Top
Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2020
Published: December 1, 2020 Content info: 123 Pages
Description

GlobalData's Medical Devices sector report, "Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hip Reconstruction Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hip Reconstruction or Hip Replacement is a procedure which involves replacement of the damaged or diseased parts of the hip joint. This category includes devices (implants) used in the Hip Replacement procedures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hip Reconstruction Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hip Reconstruction Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hip Reconstruction Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME1077EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Hip Reconstruction Overview

3 Products under Development

  • 3.1 Hip Reconstruction - Pipeline Products by Stage of Development
  • 3.2 Hip Reconstruction - Pipeline Products by Segment
  • 3.3 Hip Reconstruction - Pipeline Products by Territory
  • 3.4 Hip Reconstruction - Pipeline Products by Regulatory Path
  • 3.5 Hip Reconstruction - Pipeline Products by Estimated Approval Date
  • 3.6 Hip Reconstruction - Ongoing Clinical Trials

4 Hip Reconstruction - Pipeline Products under Development by Companies

  • 4.1 Hip Reconstruction Companies - Pipeline Products by Stage of Development
  • 4.2 Hip Reconstruction - Pipeline Products by Stage of Development

5 Hip Reconstruction Companies and Product Overview

  • 5.1 4WEB Medical Inc Company Overview
    • 5.1.1 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 BioPoly RS LLC Company Overview
    • 5.2.1 BioPoly RS LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Biotechni SAS Company Overview
    • 5.3.1 Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Bonovo Orthopedics Inc Company Overview
    • 5.4.1 Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Corin Group Ltd Company Overview
    • 5.5.1 Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 DePuy Synthes Inc Company Overview
    • 5.6.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Dynamic Implant Inc Company Overview
    • 5.7.1 Dynamic Implant Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Embody Orthopaedic Ltd Company Overview
    • 5.8.1 Embody Orthopaedic Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Exactech Inc Company Overview
    • 5.9.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 FH Ortho Inc Company Overview
    • 5.10.1 FH Ortho Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Flexable Orthopedics Company Overview
    • 5.11.1 Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Fortis Orthopedics Company Overview
    • 5.12.1 Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Fraunhofer Institute for Applied Polymer Research Company Overview
    • 5.13.1 Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Fuse Medical Inc Company Overview
    • 5.14.1 Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Hip Innovation Technology LLC Company Overview
    • 5.15.1 Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Implants International Ltd Company Overview
    • 5.16.1 Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Inor Medical Products Ltd Company Overview
    • 5.17.1 Inor Medical Products Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 JRI Orthopaedics Ltd Company Overview
    • 5.18.1 JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 KYOCERA Medical Corp Company Overview
    • 5.19.1 KYOCERA Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Lifespans Ltd Company Overview
    • 5.20.1 Lifespans Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Limacorporate SpA Company Overview
    • 5.21.1 Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 MicroPort Orthopedics Inc Company Overview
    • 5.22.1 MicroPort Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 MicroPort Scientific Corp Company Overview
    • 5.23.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 MX Orthopedics Corp Company Overview
    • 5.24.1 MX Orthopedics Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Nano Interface Technology LLC (Inactive) Company Overview
    • 5.25.1 Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 OrthoGrid Systems Company Overview
    • 5.26.1 OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 PreSRV Ltd. Company Overview
    • 5.27.1 PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Pro-Dex Inc Company Overview
    • 5.28.1 Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Renova Orthopedics LLC (Inactive) Company Overview
    • 5.29.1 Renova Orthopedics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Rochester Institute of Technology Company Overview
    • 5.30.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 SINTEF Company Overview
    • 5.31.1 SINTEF Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 SINTX Technologies Inc Company Overview
    • 5.32.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 Smith & Nephew Inc Company Overview
    • 5.33.1 Smith & Nephew Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Smith & Nephew Plc Company Overview
    • 5.34.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 Stanford University Company Overview
    • 5.35.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 University of Auckland Company Overview
    • 5.36.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 University of South Florida Company Overview
    • 5.37.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 University of Southampton Company Overview
    • 5.38.1 University of Southampton Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 University of Warwick Company Overview
    • 5.39.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 X-NOV Company Overview
    • 5.40.1 X-NOV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 Zimmer Biomet Holdings Inc Company Overview
    • 5.41.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hip Reconstruction- Recent Developments

  • 6.1 Sep 16, 2020: Willamette Surgery Center now offering highly advanced robotic-arm assisted joint replacement procedures with Stryker's mako system
  • 6.2 Jun 30, 2020: HSS study identifies RA patients with worse outcomes after hip or knee replacement
  • 6.3 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
  • 6.4 Jun 08, 2020: No difference in outcomes between anterior and posterior surgical approaches for outpatient total hip replacement
  • 6.5 May 28, 2020: Conformis announces settlement of patent dispute
  • 6.6 Apr 08, 2020: Wright Medical Group announces virtual meeting alternative to physical attendance at Extraordinary General Meeting of Shareholders and change of time and location of meeting
  • 6.7 Mar 03, 2020: Implanet steps up development in Germany and consolidates its organization
  • 6.8 Mar 02, 2020: Stryker announces new Investor Relations leader
  • 6.9 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
  • 6.10 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
  • 6.11 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
  • 6.12 Feb 18, 2020: Medtronic reports third quarter financial results 2020
  • 6.13 Feb 09, 2020: Real world evidence shows accelerated surgery in patients with hip fracture has substantial benefits
  • 6.14 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan
  • 6.15 Feb 05, 2020: Stryker expands Flower Mound regional headquarters
  • 6.16 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
  • 6.17 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors
  • 6.18 Jan 30, 2020: Conformis achieves 100,000 implant milestone for patient-specific knee replacement technology
  • 6.19 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
  • 6.20 Jan 23, 2020: Brainlab acquires San Diego-based VisionTree Software
  • 6.21 Jan 16, 2020: LimaCorporate inaugurates the new Research & Innovation Center for 3D printing and the Advanced Laboratory for Testing and Analysis (ATLAs)
  • 6.22 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience
  • 6.23 Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
  • 6.24 Jan 06, 2020: Naviswiss wins Japan approval
  • 6.25 Jan 06, 2020: Exactech announces leadership transition
  • 6.26 Dec 19, 2019: World-Renowned Neurosurgeon selected to lead nationally-recognized Henry Ford Medical Group
  • 6.27 Dec 12, 2019: BRAIN AG publishes preliminary results for the financial year 2018/19
  • 6.28 Dec 09, 2019: Creating a system of connected technologies to transform the future of orthopaedic surgery through VELYS Digital Surgery
  • 6.29 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business
  • 6.30 Dec 05, 2019: Medacta Group announces a revision of the full year guidance
  • 6.31 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Hip Reconstruction - Pipeline Products by Stage of Development
  • Table 2: Hip Reconstruction - Pipeline Products by Segment
  • Table 3: Hip Reconstruction - Pipeline Products by Territory
  • Table 4: Hip Reconstruction - Pipeline Products by Regulatory Path
  • Table 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date
  • Table 6: Hip Reconstruction - Ongoing Clinical Trials
  • Table 7: Hip Reconstruction Companies - Pipeline Products by Stage of Development
  • Table 8: Hip Reconstruction - Pipeline Products by Stage of Development
  • Table 9: 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Truss Implant - Hip Procedures - Product Status
  • Table 11: Truss Implant - Hip Procedures - Product Description
  • Table 12: BioPoly RS LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Biopoly RS Partial Resurfacing System - Hip - Product Status
  • Table 14: Biopoly RS Partial Resurfacing System - Hip - Product Description
  • Table 15: Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: MULTI-T64 - Product Status
  • Table 17: MULTI-T64 - Product Description
  • Table 18: MULTI-T66 - Product Status
  • Table 19: MULTI-T66 - Product Description
  • Table 20: Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: JMM Total Hip System - Product Status
  • Table 22: JMM Total Hip System - Product Description
  • Table 23: Konknow Hip System - Product Status
  • Table 24: Konknow Hip System - Product Description
  • Table 25: Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Trinity Plus - Product Status
  • Table 27: Trinity Plus - Product Description
  • Table 28: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Bone Preserving Hip Stem - Product Status
  • Table 30: Bone Preserving Hip Stem - Product Description
  • Table 31: Hip Resurfacing System - Product Status
  • Table 32: Hip Resurfacing System - Product Description
  • Table 33: New Poly Hip Bearing - Product Status
  • Table 34: New Poly Hip Bearing - Product Description
  • Table 35: Next Generation Hip System - Product Status
  • Table 36: Next Generation Hip System - Product Description
  • Table 37: Dynamic Implant Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Dynamic Implant - Hip Arthritis - Product Status
  • Table 39: Dynamic Implant - Hip Arthritis - Product Description
  • Table 40: Embody Orthopaedic Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: H1 Hip Resurfacing Implant - Product Status
  • Table 42: H1 Hip Resurfacing Implant - Product Description
  • Table 43: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Alteon Hip Wedge Stem - Product Status
  • Table 45: Alteon Hip Wedge Stem - Product Description
  • Table 46: Alteon Revision Modular System - Product Status
  • Table 47: Alteon Revision Modular System - Product Description
  • Table 48: Hip Revision System - Product Status
  • Table 49: Hip Revision System - Product Description
  • Table 50: FH Ortho Inc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

List of Figures

  • Figure 1: Hip Reconstruction - Pipeline Products by Stage of Development
  • Figure 2: Hip Reconstruction - Pipeline Products by Segment
  • Figure 3: Hip Reconstruction - Pipeline Products by Territory
  • Figure 4: Hip Reconstruction - Pipeline Products by Regulatory Path
  • Figure 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date
  • Figure 6: Hip Reconstruction - Ongoing Clinical Trials
Back to Top